Literature DB >> 23733886

The LXR-IDOL axis defines a clathrin-, caveolae-, and dynamin-independent endocytic route for LDLR internalization and lysosomal degradation.

Vincenzo Sorrentino1, Jessica K Nelson1, Elena Maspero2, André R A Marques1, Lilith Scheer1, Simona Polo3, Noam Zelcer4.   

Abstract

Low density lipoprotein (LDL) cholesterol is taken up into cells via clathrin-mediated endocytosis of the LDL receptor (LDLR). Following dissociation of the LDLR-LDL complex, LDL is directed to lysosomes whereas the LDLR recycles to the plasma membrane. Activation of the sterol-sensing nuclear receptors liver X receptors (LXRs) enhances degradation of the LDLR. This depends on the LXR target gene inducible degrader of the LDLR (IDOL), an E3-ubiquitin ligase that promotes ubiquitylation and lysosomal degradation of the LDLR. How ubiquitylation of the LDLR by IDOL controls its endocytic trafficking is currently unknown. Using genetic- and pharmacological-based approaches coupled to functional assessment of LDL uptake, we show that the LXR-IDOL axis targets a LDLR pool present in lipid rafts. IDOL-dependent internalization of the LDLR is independent of clathrin, caveolin, macroautophagy, and dynamin. Rather, it depends on the endocytic protein epsin. Consistent with LDLR ubiquitylation acting as a sorting signal, degradation of the receptor can be blocked by perturbing the endosomal sorting complex required for transport (ESCRT) or by USP8, a deubiquitylase implicated in sorting ubiquitylated cargo to multivesicular bodies. In summary, we provide evidence for the existence of an LXR-IDOL-mediated internalization pathway for the LDLR that is distinct from that used for lipoprotein uptake.

Entities:  

Keywords:  E3-ubiquitin ligase; endocytosis; epsins; inducible degrader of low density lipoprotein receptor; lipoprotein receptors; liver X receptor; low density lipoprotein receptor

Mesh:

Substances:

Year:  2013        PMID: 23733886      PMCID: PMC3708367          DOI: 10.1194/jlr.M037713

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  56 in total

1.  The E3 ubiquitin ligase AIP4 mediates ubiquitination and sorting of the G protein-coupled receptor CXCR4.

Authors:  Adriano Marchese; Camilla Raiborg; Francesca Santini; James H Keen; Harald Stenmark; Jeffrey L Benovic
Journal:  Dev Cell       Date:  2003-11       Impact factor: 12.270

Review 2.  The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins.

Authors:  Camilla Raiborg; Harald Stenmark
Journal:  Nature       Date:  2009-03-26       Impact factor: 49.962

3.  A dominant negative form of the AAA ATPase SKD1/VPS4 impairs membrane trafficking out of endosomal/lysosomal compartments: class E vps phenotype in mammalian cells.

Authors:  Hideaki Fujita; Motoko Yamanaka; Kanako Imamura; Yoshitaka Tanaka; Atsuki Nara; Tamotsu Yoshimori; Sadaki Yokota; Masaru Himeno
Journal:  J Cell Sci       Date:  2003-01-15       Impact factor: 5.285

Review 4.  A receptor-mediated pathway for cholesterol homeostasis.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

Review 5.  The LDL receptor.

Authors:  Joseph L Goldstein; Michael S Brown
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-04       Impact factor: 8.311

6.  ARH is a modular adaptor protein that interacts with the LDL receptor, clathrin, and AP-2.

Authors:  Guocheng He; Sarita Gupta; Ming Yi; Peter Michaely; Helen H Hobbs; Jonathan C Cohen
Journal:  J Biol Chem       Date:  2002-09-08       Impact factor: 5.157

7.  Epsin 1 is involved in recruitment of ubiquitinated EGF receptors into clathrin-coated pits.

Authors:  Maja Kazazic; Vibeke Bertelsen; Ketil Winther Pedersen; Tram Thu Vuong; Michael Vibo Grandal; Marianne Skeie Rødland; Linton M Traub; Espen Stang; Inger Helene Madshus
Journal:  Traffic       Date:  2008-11-20       Impact factor: 6.215

8.  The epidermal growth factor homology domain of the LDL receptor drives lipoprotein release through an allosteric mechanism involving H190, H562, and H586.

Authors:  Zhenze Zhao; Peter Michaely
Journal:  J Biol Chem       Date:  2008-08-03       Impact factor: 5.157

9.  The J.D. mutation in familial hypercholesterolemia: amino acid substitution in cytoplasmic domain impedes internalization of LDL receptors.

Authors:  C G Davis; M A Lehrman; D W Russell; R G Anderson; M S Brown; J L Goldstein
Journal:  Cell       Date:  1986-04-11       Impact factor: 41.582

10.  Clathrin-mediated endocytosis in AP-2-depleted cells.

Authors:  Alison Motley; Nicholas A Bright; Matthew N J Seaman; Margaret S Robinson
Journal:  J Cell Biol       Date:  2003-09-01       Impact factor: 10.539

View more
  22 in total

Review 1.  Molecular pathways: sterols and receptor signaling in cancer.

Authors:  Linara Gabitova; Andrey Gorin; Igor Astsaturov
Journal:  Clin Cancer Res       Date:  2013-10-24       Impact factor: 12.531

Review 2.  Hepatitis C virus relies on lipoproteins for its life cycle.

Authors:  Germana Grassi; Giorgia Di Caprio; Gian Maria Fimia; Giuseppe Ippolito; Marco Tripodi; Tonino Alonzi
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

3.  The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance.

Authors:  Melinde Wijers; Paolo Zanoni; Nalan Liv; Dyonne Y Vos; Michelle Y Jäckstein; Marieke Smit; Sanne Wilbrink; Justina C Wolters; Ydwine T van der Veen; Nicolette Huijkman; Daphne Dekker; Niels Kloosterhuis; Theo H van Dijk; Daniel D Billadeau; Folkert Kuipers; Judith Klumperman; Arnold von Eckardstein; Jan Albert Kuivenhoven; Bart van de Sluis
Journal:  JCI Insight       Date:  2019-06-06

4.  The LXR-Idol axis differentially regulates plasma LDL levels in primates and mice.

Authors:  Cynthia Hong; Stephanie M Marshall; Allison L McDaniel; Mark Graham; Joseph D Layne; Lei Cai; Elena Scotti; Rima Boyadjian; Jason Kim; Brian T Chamberlain; Rajendra K Tangirala; Michael E Jung; Loren Fong; Richard Lee; Stephen G Young; Ryan E Temel; Peter Tontonoz
Journal:  Cell Metab       Date:  2014-11-04       Impact factor: 27.287

5.  A MARCH6 and IDOL E3 Ubiquitin Ligase Circuit Uncouples Cholesterol Synthesis from Lipoprotein Uptake in Hepatocytes.

Authors:  Anke Loregger; Emma Claire Laura Cook; Jessica Kristin Nelson; Martina Moeton; Laura Jane Sharpe; Susanna Engberg; Madina Karimova; Gilles Lambert; Andrew John Brown; Noam Zelcer
Journal:  Mol Cell Biol       Date:  2015-11-02       Impact factor: 4.272

Review 6.  LXR Regulation of Brain Cholesterol: From Development to Disease.

Authors:  Rebecca Courtney; Gary E Landreth
Journal:  Trends Endocrinol Metab       Date:  2016-04-21       Impact factor: 12.015

7.  Myeloid-Specific Deletion of Epsins 1 and 2 Reduces Atherosclerosis by Preventing LRP-1 Downregulation.

Authors:  Megan L Brophy; Yunzhou Dong; Huan Tao; Patricia G Yancey; Kai Song; Kun Zhang; Aiyun Wen; Hao Wu; Yang Lee; Marina V Malovichko; Srinivas D Sithu; Scott Wong; Lili Yu; Olivier Kocher; Joyce Bischoff; Sanjay Srivastava; MacRae F Linton; Klaus Ley; Hong Chen
Journal:  Circ Res       Date:  2019-02-15       Impact factor: 17.367

Review 8.  Liver X receptors in lipid metabolism: opportunities for drug discovery.

Authors:  Cynthia Hong; Peter Tontonoz
Journal:  Nat Rev Drug Discov       Date:  2014-05-16       Impact factor: 84.694

9.  3-Deoxyschweinfurthin B Lowers Cholesterol Levels by Decreasing Synthesis and Increasing Export in Cultured Cancer Cell Lines.

Authors:  Craig H Kuder; Megan M Weivoda; Ying Zhang; Junjia Zhu; Jeffrey D Neighbors; David F Wiemer; Raymond J Hohl
Journal:  Lipids       Date:  2015-10-22       Impact factor: 1.880

10.  Deubiquitylase Inhibition Reveals Liver X Receptor-independent Transcriptional Regulation of the E3 Ubiquitin Ligase IDOL and Lipoprotein Uptake.

Authors:  Jessica Kristine Nelson; Emma Clare Laura Cook; Anke Loregger; Marten Anne Hoeksema; Saskia Scheij; Igor Kovacevic; Peter Lodewijk Hordijk; Huib Ovaa; Noam Zelcer
Journal:  J Biol Chem       Date:  2015-12-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.